Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH1 | P35367 | 17/20 | 0.46 |
| ▸ | CCR3 | P51677 | 17/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.41 |
| ▸ | FPR2 | P25090 | 2/20 | 0.40 |
| ▸ | PROKR1 | Q8TCW9 | 2/20 | 0.40 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6569229 | 0.83 | HRH1 (0.47) | HRH1CCR3KCNH2P2RX7 | |
| SCHEMBL6569359 | 0.81 | HRH1 (0.38) | HRH1CCR3KCNH2P2RX7 | |
| SCHEMBL6570411 | 0.79 | HRH1 (0.45) | HRH1CCR3KCNH2P2RX7 | |
| SCHEMBL6569264 | 0.79 | CA1 (0.37) | HRH1CCR3KCNH2FPR2PROKR1 | |
| SCHEMBL6570601 | 0.78 | HRH1 (0.43) | HRH1CCR3KCNH2 | |
| SCHEMBL6569095 | 0.77 | HRH1 (0.42) | HRH1CCR3KCNH2 | |
| SCHEMBL6569275 | 0.76 | HRH1 (0.46) | HRH1CCR3KCNH2 | |
| SCHEMBL7016612 | 0.74 | HRH1 (0.41) | HRH1CCR3KCNH2FPR2PROKR1 | |
| SCHEMBL6569255 | 0.74 | HRH1 (0.39) | HRH1CCR3KCNH2 | |
| SCHEMBL6681927 | 0.74 | SLC6A4 (0.43) | HRH1CCR3KCNH2FPR2PROKR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1404667-A1 | PIPERIDINE DERIVATIVES USEFUL AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | AstraZeneca AB (SE) | 2004-04-07 | — | — | EP | disclosed |
| WO-2003004487-A1 | PIPERIDINE DERIVATIVES USEFUL AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | ASTRAZENECA AB (SE) | 2003-01-16 | — | — | WO | disclosed |